These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133254)

  • 1. Opiate activity and receptor selectivity of dynorphin1-13 and related peptides.
    Wüster M; Schulz R; Herz A
    Neurosci Lett; 1980 Oct; 20(1):79-83. PubMed ID: 6133254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin1-13: interaction with other opiate ligand bindings in vitro.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Brain Res; 1984 Jun; 302(2):392-6. PubMed ID: 6329465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor binding profile of [3H]dynorphin A-(1-8) in rat and guinea pig brain.
    Quirion R; Pilapil C
    Eur J Pharmacol; 1984 Apr; 99(4):361-3. PubMed ID: 6329791
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens.
    Wüster M; Schulz R; Herz A
    Eur J Pharmacol; 1980 Mar; 62(2-3):235-6. PubMed ID: 6103811
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus.
    Chavkin C; Goldstein A
    Nature; 1981 Jun; 291(5816):591-3. PubMed ID: 6264311
    [No Abstract]   [Full Text] [Related]  

  • 8. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A characterization of dynorphin-(1-13) on the guinea pig ileal longitudinal muscle.
    Vaught JL
    Eur J Pharmacol; 1981 Dec; 76(4):453-6. PubMed ID: 6276199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
    Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
    Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
    Corbett AD; Paterson SJ; McKnight AT; Magnan J; Kosterlitz HW
    Nature; 1982 Sep; 299(5878):79-81. PubMed ID: 6125893
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin: specific binding to opiate receptors.
    Lee NM; Landahl H
    NIDA Res Monogr; 1986; 71():19-27. PubMed ID: 2879239
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 17. Endogenous ligands for kappa-opiate receptors.
    Schulz R; Wüster M; Herz A
    Peptides; 1982; 3(6):973-6. PubMed ID: 6132366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of potassium on the potency of different opioids in the mouse vas deferens.
    Wüster M; Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):181-4. PubMed ID: 7207646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of beta h-endorphin analogs containing the dynorphin-(1-13) sequence.
    Li CH; Yamashiro D; Ferrara P; Tseng LF; Way EL
    Int J Pept Protein Res; 1983 Apr; 21(4):331-5. PubMed ID: 6305857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.